ARK Genomic Revolution ETF · $2.2B$6,090
ARKGARKG vsSCHDSCHDSchwab U.S. Dividend Equity ETF · $120B$16,267
$10,000 five years ago, dividends reinvested · they hold 0.0% in common
ARKGMeasureSCHD
Returns · dividends reinvested
+56.9%Year to dateJan 1 → Nov 6+31.4%
+52.8%1 yearTotal return+37.0%
+25.1%3 years · per year$10,000 became $19,574 · $17,266+20.0%
−9.4%5 years · per year$10,000 became $6,090 · $16,267+10.2%
Cost and income
0.75%Expense ratio$75 · $6 a year on $10k · lower is better0.06%
0.00%Trailing 12-mo yield$0 · $300 a year on $10k3.00%
Risk · past year
−27.5%Worst dropSmaller is better−6.9%
46.9%VolatilityLower is calmer11.7%
ARKGSCHD Winner of the row, in its colourEach row: the bigger of the two fills its side
3–5SCHD wins
End-of-day Nov 6, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns